Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Werlenius

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS studyKatja Werlenius, Florida Parcaoglu, Mark Zupancic, et al.
F1000Research|January 17, 2019
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trialAsgeir Store Jakola, Katja Werlenius, Munila Mudaisi, et al.
JAMA Network Open|March 31, 2023
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical TrialKatja Werlenius, Sara Kinhult, Tora Skeidsvoll Solheim, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countriesLiv Cathrine Heggebø, Taran Paulsen Hellebust, Thomas Henry, et al.
BMJ Open|March 20, 2023
Investigating survival, quality of life and cognition in PROton versus photon therapy for <i>IDH-</i>mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and SwedenLiv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS studyKatja Werlenius, Florida Parcaoglu, Mark Zupancic, et al.
F1000Research|January 17, 2019
Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trialAsgeir Store Jakola, Katja Werlenius, Munila Mudaisi, et al.
JAMA Network Open|March 31, 2023
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical TrialKatja Werlenius, Sara Kinhult, Tora Skeidsvoll Solheim, et al.
Clinical and Translational Radiation Oncology|July 1, 2026
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countriesLiv Cathrine Heggebø, Taran Paulsen Hellebust, Thomas Henry, et al.
BMJ Open|March 20, 2023
Investigating survival, quality of life and cognition in PROton versus photon therapy for <i>IDH-</i>mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and SwedenLiv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, et al.
Pageof 2